<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Atrial Fibrillation and Anticoagulation</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->4/9/2010</div></div><div class="card__content"><h1 id="atrial-fibrillation-and-anticoagulation">Atrial Fibrillation and Anticoagulation</h1>
<h2 id="background">Background</h2>
<p><strong>Atrial Fibrillation</strong> (AF) = <strong>5x</strong> risk for CVA and increases with age </p>
<ul>
<li>Patients with persistent and paroxysmal atrial fibrillation should be treated the same when it comes to deciding about anticoagulation. They have an equivalent risk of stroke.</li>
</ul>
<p><strong>Stroke risk factors for patients with AF:</strong></p>
<ul>
<li>Prior CVA or TIA</li>
<li>HTN</li>
<li>Age &ge;75</li>
<li>CHF</li>
<li>Poor LV function</li>
<li>DM</li>
</ul>
<h2 id="chads2-stroke-risk-stratification-scheme">CHADS2 stroke risk stratification scheme</h2>
<ul>
<li><strong>C</strong> = Congestive heart failure (1 pt)</li>
<li><strong>H</strong> = Hypertension (1 pt)</li>
<li><strong>A</strong> = Age &ge; 75 (1 pt)</li>
<li><strong>D</strong> = DM (1 pt)</li>
<li><strong>S2</strong> = prior Stroke or TIA (2 pts)</li>
</ul>
<p><img src="https://aliemcards.netlify.com/media/atrial-fibrillation_image-1.png" alt="Bar chart showing stroke rate as CHADS2 score increases"></p>
<p>(<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607">Gage et al., JAMA, 2001</a>)</p>
<h2 id="deciding-on-whether-to-anticoagulate-with-aspirin-or-warfarin-aha-acc-esc-2006-guidelines-">Deciding on whether to anticoagulate with aspirin or warfarin: (<a href="http://circ.ahajournals.org/content/114/7/e257.full">AHA/ACC/ESC 2006 guidelines</a>)</h2>
<h3 id="weak-risk-factors">Weak Risk Factors</h3>
<ul>
<li>Female gender    </li>
<li>Age 65-74 years        </li>
<li>Coronary artery disease               </li>
<li>Thyrotoxicosis</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li><span class="drug">Aspirin</span> or <span class="drug">warfarin</span></li>
</ul>
<h3 id="moderate-risk-factors">Moderate Risk Factors</h3>
<ul>
<li>Age &gt;75 years          </li>
<li>Hypertension                     </li>
<li>Heart failure           </li>
<li>LV ejection fracture &le;35%              </li>
<li>Diabetes mellitus </li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>1 risk factor: <span class="drug">aspirin</span> or <span class="drug">warfarin</span></li>
<li>&gt;1 risk factor: <span class="drug">warfarin</span></li>
</ul>
<h3 id="high-risk-factors">High Risk Factors</h3>
<ul>
<li>Prior CVA        </li>
<li>Prior TIA         </li>
<li>Embolism          </li>
<li>Mitral stenosis   </li>
<li>Mechanical heart valve</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li><span class="drug">Warfarin</span></li>
</ul>
<h2 id="notes">Notes</h2>
<ul>
<li>Anticoagulation goal with <span class="drug">warfarin</span>: INR 2-3</li>
<li>If age &lt;60 years AND zero risk factors: No anticoagulation because low risk for CVA </li>
</ul>
<h2 id="references">References</h2>
<ul>
<li>Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-354. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16908781">PubMed</a>]</li>
<li>Waldo AL. Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation. Cardiol Clin 2009; 27:125-35. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=19111769">PubMed</a>]</li>
<li>Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"atrial-fibrillation","title":"Atrial Fibrillation and Anticoagulation","authors":["Michelle Lin, MD"],"categories":[{"slug":"cardiovascular","name":"Cardiovascular"}],"created":"2010/04/09","updated":"2017/02/13","body":"\n# Atrial Fibrillation and Anticoagulation\n\n## Background\n\n**Atrial Fibrillation** (AF) = **5x** risk for CVA and increases with age \n\n- Patients with persistent and paroxysmal atrial fibrillation should be treated the same when it comes to deciding about anticoagulation. They have an equivalent risk of stroke.\n\n**Stroke risk factors for patients with AF:**\n\n- Prior CVA or TIA\n- HTN\n- Age \u0026ge;75\n- CHF\n- Poor LV function\n- DM\n\n## CHADS2 stroke risk stratification scheme \n\n- **C** = Congestive heart failure (1 pt)\n- **H** = Hypertension (1 pt)\n- **A** = Age \u0026ge; 75 (1 pt)\n- **D** = DM (1 pt)\n- **S2** = prior Stroke or TIA (2 pts)\n\n![Bar chart showing stroke rate as CHADS2 score increases](https://aliemcards.netlify.com/media/atrial-fibrillation_image-1.png)\n\n([Gage et al., JAMA, 2001](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607))\n\n## Deciding on whether to anticoagulate with aspirin or warfarin: ([AHA/ACC/ESC 2006 guidelines](http://circ.ahajournals.org/content/114/7/e257.full))\n\n### Weak Risk Factors\n\n- Female gender    \n- Age 65-74 years        \n- Coronary artery disease               \n- Thyrotoxicosis\n\n**Treatment**\n\n- \u003cspan class=\"drug\"\u003eAspirin\u003c/span\u003e or \u003cspan class=\"drug\"\u003ewarfarin\u003c/span\u003e\n\n### Moderate Risk Factors\n\n- Age \u003e75 years          \n- Hypertension                     \n- Heart failure           \n- LV ejection fracture \u0026le;35%              \n- Diabetes mellitus \n\n**Treatment**\n\n- 1 risk factor: \u003cspan class=\"drug\"\u003easpirin\u003c/span\u003e or \u003cspan class=\"drug\"\u003ewarfarin\u003c/span\u003e\n- \u0026gt;1 risk factor: \u003cspan class=\"drug\"\u003ewarfarin\u003c/span\u003e\n\n### High Risk Factors\n\n- Prior CVA        \n- Prior TIA         \n- Embolism          \n- Mitral stenosis   \n- Mechanical heart valve\n\n**Treatment**\n\n- \u003cspan class=\"drug\"\u003eWarfarin\u003c/span\u003e\n\n## Notes\n\n- Anticoagulation goal with \u003cspan class=\"drug\"\u003ewarfarin\u003c/span\u003e: INR 2-3\n- If age \u0026lt;60 years AND zero risk factors: No anticoagulation because low risk for CVA \n\n## References\n\n- Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-354. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/16908781)]\n- Waldo AL. Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation. Cardiol Clin 2009; 27:125-35. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=19111769)]\n- Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"atrial-fibrillation"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>